Regulatory Guidance on Adaptive Methods in Rare Disease Trials
Regulatory Guidance on Adaptive Methods in Rare Disease Trials Navigating Regulatory Guidance on Adaptive Designs in Rare Disease Trials Introduction: Regulatory Confidence in Adaptive Methods Adaptive designs offer a lifeline for efficient clinical development in rare diseases, where patient populations are small and traditional trial models are often unfeasible. However, this flexibility must operate within…
Read More “Regulatory Guidance on Adaptive Methods in Rare Disease Trials” »